These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2361 related articles for article (PubMed ID: 33981038)

  • 1. DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer.
    Mao C; Liu X; Zhang Y; Lei G; Yan Y; Lee H; Koppula P; Wu S; Zhuang L; Fang B; Poyurovsky MV; Olszewski K; Gan B
    Nature; 2021 May; 593(7860):586-590. PubMed ID: 33981038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A ferroptosis defense mechanism mediated by glycerol-3-phosphate dehydrogenase 2 in mitochondria.
    Wu S; Mao C; Kondiparthi L; Poyurovsky MV; Olszewski K; Gan B
    Proc Natl Acad Sci U S A; 2022 Jun; 119(26):e2121987119. PubMed ID: 35749365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Redistribution of defective mitochondria-mediated dihydroorotate dehydrogenase imparts 5-fluorouracil resistance in colorectal cancer.
    Dong S; Zhang M; Cheng Z; Zhang X; Liang W; Li S; Li L; Xu Q; Song S; Liu Z; Yang G; Zhao X; Tao Z; Liang S; Wang K; Zhang G; Hu S
    Redox Biol; 2024 Jul; 73():103207. PubMed ID: 38805974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DHODH tangoing with GPX4 on the ferroptotic stage.
    Wang F; Min J
    Signal Transduct Target Ther; 2021 Jun; 6(1):244. PubMed ID: 34145214
    [No Abstract]   [Full Text] [Related]  

  • 5. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis.
    Bersuker K; Hendricks JM; Li Z; Magtanong L; Ford B; Tang PH; Roberts MA; Tong B; Maimone TJ; Zoncu R; Bassik MC; Nomura DK; Dixon SJ; Olzmann JA
    Nature; 2019 Nov; 575(7784):688-692. PubMed ID: 31634900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FSP1 is a glutathione-independent ferroptosis suppressor.
    Doll S; Freitas FP; Shah R; Aldrovandi M; da Silva MC; Ingold I; Goya Grocin A; Xavier da Silva TN; Panzilius E; Scheel CH; Mourão A; Buday K; Sato M; Wanninger J; Vignane T; Mohana V; Rehberg M; Flatley A; Schepers A; Kurz A; White D; Sauer M; Sattler M; Tate EW; Schmitz W; Schulze A; O'Donnell V; Proneth B; Popowicz GM; Pratt DA; Angeli JPF; Conrad M
    Nature; 2019 Nov; 575(7784):693-698. PubMed ID: 31634899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel mitochondria-targeting DHODH inhibitor induces robust ferroptosis and alleviates immune suppression.
    Hai Y; Fan R; Zhao T; Lin R; Zhuang J; Deng A; Meng S; Hou Z; Wei G
    Pharmacol Res; 2024 Apr; 202():107115. PubMed ID: 38423231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The glutathione peroxidase Gpx4 prevents lipid peroxidation and ferroptosis to sustain Treg cell activation and suppression of antitumor immunity.
    Xu C; Sun S; Johnson T; Qi R; Zhang S; Zhang J; Yang K
    Cell Rep; 2021 Jun; 35(11):109235. PubMed ID: 34133924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploiting Cancer Vulnerabilities by Blocking of the DHODH and GPX4 Pathways: A Multifunctional Bodipy/PROTAC Nanoplatform for the Efficient Synergistic Ferroptosis Therapy.
    Yao L; Yang N; Zhou W; Akhtar MH; Zhou W; Liu C; Song S; Li Y; Han W; Yu C
    Adv Healthc Mater; 2023 Oct; 12(26):e2300871. PubMed ID: 37204046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Warburg effect modulates DHODH role in ferroptosis: a review.
    Amos A; Amos A; Wu L; Xia H
    Cell Commun Signal; 2023 May; 21(1):100. PubMed ID: 37147673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Manganese induces tumor cell ferroptosis through type-I IFN dependent inhibition of mitochondrial dihydroorotate dehydrogenase.
    Zhang S; Kang L; Dai X; Chen J; Chen Z; Wang M; Jiang H; Wang X; Bu S; Liu X; Zhang G; Tang H
    Free Radic Biol Med; 2022 Nov; 193(Pt 1):202-212. PubMed ID: 36228830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of glutathione peroxidase 4 and intracellular iron level in ovarian cancer cells-"utilization" of ferroptosis mechanism.
    Li D; Zhang M; Chao H
    Inflamm Res; 2021 Dec; 70(10-12):1177-1189. PubMed ID: 34537856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondria-Targeted Prodrug Nanoassemblies for Efficient Ferroptosis-Based Therapy via Devastating Ferroptosis Defense Systems.
    Liu N; Lin Q; Huang Z; Liu C; Qin J; Yu Y; Chen W; Zhang J; Jiang M; Gao X; Huo S; Zhu X
    ACS Nano; 2024 Mar; 18(11):7945-7958. PubMed ID: 38452275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ketamine Induces Ferroptosis of Liver Cancer Cells by Targeting lncRNA PVT1/miR-214-3p/GPX4.
    He GN; Bao NR; Wang S; Xi M; Zhang TH; Chen FS
    Drug Des Devel Ther; 2021; 15():3965-3978. PubMed ID: 34566408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutathione depletion and dihydroorotate dehydrogenase inhibition actuated ferroptosis-augment to surmount triple-negative breast cancer.
    Zhou TJ; Zhang MM; Liu DM; Huang LL; Yu HQ; Wang Y; Xing L; Jiang HL
    Biomaterials; 2024 Mar; 305():122447. PubMed ID: 38154441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Luteolin exhibits synergistic therapeutic efficacy with erastin to induce ferroptosis in colon cancer cells through the HIC1-mediated inhibition of GPX4 expression.
    Zheng Y; Li L; Chen H; Zheng Y; Tan X; Zhang G; Jiang R; Yu H; Lin S; Wei Y; Wang Y; Zhang R; Liu Z; Wu J
    Free Radic Biol Med; 2023 Nov; 208():530-544. PubMed ID: 37717793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A targetable PRR11-DHODH axis drives ferroptosis- and temozolomide-resistance in glioblastoma.
    Miao Z; Xu L; Gu W; Ren Y; Li R; Zhang S; Chen C; Wang H; Ji J; Chen J
    Redox Biol; 2024 Jul; 73():103220. PubMed ID: 38838551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial pyruvate carrier 1 regulates ferroptosis in drug-tolerant persister head and neck cancer cells via epithelial-mesenchymal transition.
    You JH; Lee J; Roh JL
    Cancer Lett; 2021 Jun; 507():40-54. PubMed ID: 33741422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of SRSF9 enhances the sensitivity of colorectal cancer to erastin-induced ferroptosis by reducing glutathione peroxidase 4 expression.
    Wang R; Su Q; Yin H; Wu D; Lv C; Yan Z
    Int J Biochem Cell Biol; 2021 May; 134():105948. PubMed ID: 33609745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PITX2 functions as a transcription factor for GPX4 and protects pancreatic cancer cells from ferroptosis.
    Wang Z; Wu D; Zhang Y; Chen W; Yang Y; Yang Y; Zu G; An Y; Yu X; Qin Y; Xu X; Chen X
    Exp Cell Res; 2024 Jun; 439(1):114074. PubMed ID: 38710403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 119.